Trial Profile
Aflibercept treat and extend for macular edema secondary to branch retinal vein occlusion
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 25 Apr 2017
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary)
- Indications Branch retinal vein occlusion; Retinal oedema
- Focus Therapeutic Use
- 25 Apr 2017 New trial record